Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome.
Intravenous immunoglobulin (IVIg) therapy is being increasingly used in a wide range of neurological conditions. However, treatment is expensive and side effects may be severe. A patient with Miller Fisher syndrome who developed cortical blindness as a consequence of occipital infarction precipitated by IVIg is reported on.
Turner
B
B
Division of Clinical Neurology, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, UK. nnxbt@nnn1.nottingham.ac.uk
Wills
A J
AJ
D019575:Blindness, Cortical / Q000139:chemically induced* / Q000175:diagnosis; D002169:Campylobacter Infections / Q000150:complications / Q000628:therapy; D016123:Campylobacter jejuni; D002544:Cerebral Infarction / Q000139:chemically induced* / Q000175:diagnosis; D004751:Enteritis / Q000150:complications / Q000175:diagnosis; D005260:Female; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D019846:Miller Fisher Syndrome / Q000175:diagnosis / Q000628:therapy*; D009460:Neurologic Examination; D009778:Occipital Lobe / Q000098:blood supply*